ClinicalTrials.gg
CompletedNCT07300748Updated Jun 17, 2026

Effectiveness of Cardiopulmonary Exercises for Children With Pectus Excavatum

An interventional study of Cardiopulmonary exercises at hospital and Pulmonary and posture exercises at home in Pectus Excavatum Deformity, sponsored by Ankara Etlik City Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by Ankara Etlik City Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Study summary

The aim of this study is to investigate the effects of cardiopulmonary rehabilitation on respiratory function, exercise tolerance and posture in patients with pectus excavatum.

02

Conditions studied

  • Pectus Excavatum Deformity

Browse trials for

Keywords

  • pectus excavatum
  • cardiopulmonary exercises
03

In context

Funnel Chest

79 studies on the registry are indexed under Funnel Chest; 10 are open to participants now.

This study's enrollment of 50 is above the median of 40 across 46 interventional studies indexed under Funnel Chest.

Browse Funnel Chest studies →

Lead sponsor

Ankara Etlik City Hospital is the lead sponsor of 176 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children aged 5-18 years with pectus excavatum deformity
  2. Children undergoing conservative treatment (vacuum orthosis, exercise)
  3. Patients whose families have signed a consent form agreeing to participate in the study

Exclusion criteria

Exclusion Criteria:

  1. Known cardiac disease
  2. Presence of an additional syndrome (Marfan syndrome, etc.)
  3. Cobb angle ≥10°
  4. Refusal to participate in the study
  5. Presence of mixed deformity (pectus arcuatum)
  6. Those with an indication for surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    cardiopulmonary exercises group at hospital

    The working group will be provided with a personalised exercise plan by a physiotherapist specialising in that field at the cardiopulmonary rehabilitation unit, to be carried out twice a week for five weeks. Patients will work on a bicycle ergometer. In addition, the same physiotherapist will demonstrate breathing and posture exercises for patients to perform at home.

    Other: Cardiopulmonary exercises at hospital

  • Active comparator
    pulmonary exercises group at home

    The physiotherapist will only demonstrate the breathing and posture exercises that patients in the control group will perform at home.

    Other: Pulmonary and posture exercises at home

Interventions

  • OtherCardiopulmonary exercises at hospital

    Patients will exercise using a bicycle ergometer. In addition, the same physiotherapist will demonstrate breathing and posture exercises for them to perform at home.

  • OtherPulmonary and posture exercises at home

    The physiotherapist will demonstrate the breathing and posture exercises to be performed at home.

06

What researchers measure

Primary outcomes

  1. Maximal inspiration and expiration pressure

    Time frame: first day of exercises program and 5th week of exercises program

Secondary outcomes

  1. 6 minute walking test

    Time frame: first day of exercises program and 5th week of exercises program

  2. New York Posture Scale

    Time frame: first day of exercises program and 5th week of exercises program

  3. Measurement of chest expansion in centimetres using a tape measure

    Time frame: first day of exercises program and 5th week of exercises program

  4. Assessment of symptoms (exercise intolerance, psychological impact, resting dyspnoea, chest pain, spinal pain, gastrointestinal symptoms, palpitations, dyspnoea) using a visual analogue scale

    Time frame: first day of exercises program and 5th week of exercises program

  5. Cobb angle analysis using the Diers Formatrix 4D device (Wiesbaden, Germany)

    Time frame: first day of exercises program and 5th week of exercises program

  6. Thoracic kyphosis angle

    Time frame: first day of exercises program and 5th week of exercises program

  7. body lenght

    Time frame: first day of exercises program and 5th week of exercises program

  8. Saggital balance angle using the Diers Formatrix 4D device (Wiesbaden, Germany)

    Time frame: first day of exercises program and 5th week of exercises program

  9. Coronal balance angle using the Diers Formatrix 4D device (Wiesbaden, Germany)

    Time frame: first day of exercises program and 5th week of exercises program

  10. pelvic obliquity angle using the Diers Formatrix 4D device (Wiesbaden, Germany)

    Time frame: first day of exercises program and 5th week of exercises program

07

Study locations

1 site
  • Ankara Etlik City Hospital
    Ankara, Yenimahalle 06010, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07300748
Responsible party
Ayse Naz Kalem (PM&R Specialist, Ankara Etlik City Hospital) — Principal investigator
First posted
Dec 24, 2025
Start date
Dec 9, 2025
Primary completion
May 9, 2026
Completion
May 9, 2026
Last update
Jun 17, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion